Analyst Price Targets — GEHC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 12:11 pm | — | UBS | $67.00 | $64.23 | TheFly | GE HealthCare price target lowered to $67 from $69 at UBS |
| July 13, 2026 11:20 am | Ryan Zimmerman | BTIG | $75.00 | $64.70 | TheFly | GE HealthCare price target lowered to $75 from $80 at BTIG |
| July 8, 2026 8:35 pm | — | BMO Capital | $70.00 | $64.68 | TheFly | GE HealthCare initiated with a Market Perform at BMO Capital |
| June 23, 2026 9:31 am | — | RBC Capital | $80.00 | $60.64 | TheFly | GE HealthCare initiated with an Outperform at RBC Capital |
| May 21, 2026 7:06 am | Graham Doyle | UBS | $69.00 | $64.26 | StreetInsider | UBS Upgrades GE HealthCare (GEHC) to Neutral |
| April 30, 2026 12:17 pm | — | Evercore ISI | $80.00 | $59.81 | TheFly | GE HealthCare price target lowered to $80 from $85 at Evercore ISI |
| April 30, 2026 11:58 am | Suraj Kalia | Oppenheimer | $85.00 | $60.04 | TheFly | GE HealthCare price target lowered to $85 from $89 at Oppenheimer |
| April 30, 2026 9:34 am | Matt Miksic | Barclays | $78.00 | $59.49 | TheFly | GE HealthCare price target lowered to $78 from $87 at Barclays |
| April 30, 2026 8:28 am | David Roman | Goldman Sachs | $65.00 | $59.49 | TheFly | GE HealthCare downgraded to Neutral from Buy at Goldman Sachs |
| April 29, 2026 5:50 pm | — | Stifel Nicolaus | $80.00 | $60.06 | TheFly | GE HealthCare price target lowered to $80 from $98 at Stifel |
Latest News for GEHC
GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.
ROCKVILLE CENTRE, N.Y.--(BUSINESS WIRE)--Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (Nasdaq: GEHC) announced today a 10-year strategic partnership, known as a Care Alliance, valued at approximately $500 million, to help expand access to advanced imaging, precision diagnostics and AI-enabled technology across Catholic Health in support of innovative, compassionate and…
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.
LOS ANGELES, July 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GEHC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.